The risk of bloodstream infections increases in patients undergoing chronic hemodialysis, primarily due to water contamination or improper handling during dialyzer reprocessing. This study aimed to identify virulence factors and gather epidemiological data on the Burkholderia cepacia complex (Bcc), isolated from water and blood cultures during an outbreak in a hemodialysis unit. We analyzed 33 Bcc isolates from blood cultures of patients with bacteremia undergoing hemodialysis and 24 isolates from water samples collected between 2019 and 2022. All isolates were tested for virulence factor-encoding genes, including cblA, esmR, zmpA, and zmpB, using polymerase chain reaction (PCR) assays. The isolates were further characterized using Multi-Locus Sequence Typing (MLST) and Pulsed-Field Gel Electrophoresis (PFGE). Biofilm production was assessed on polystyrene microplates at 20°C and 35°C. The genes zmpB and zmpA were present in 100 % and 96.5 % of the isolates, respectively. However, none of the isolates carried the cblA or esmR genes. Within the Bcc, the species B. cepacia (genomovar I) was identified through recA gene sequencing. PFGE analysis revealed that all human- and water-derived isolates shared the same pulsotype, classified as ST-767. Despite routine water disinfection with peracetic acid, the detection of a single pulsotype of this species over three years indicates the persistent of Burkholderia cepacia ST 767 in the plumbing system, leading to the contamination of patients undergoing hemodialysis. This persistence is likely facilitated by biofilm formation, as all water-derived isolates demonstrated biofilm production at 20°C. To exacerbate the situation, all isolates exhibited multidrug resistance, further complicating patient treatment and management.
Escherichia albertii is a pathogen that causes sporadic cases and outbreaks of diarrhea. The main virulence feature of this bacterium is the attaching and effacing (AE) lesion formation on infected intestinal epithelial cells, which is characterized by the formation of pedestal-like structures that are rich in F-actin. The Brazilian E. albertii 1551-2 strain can recruit F-actin using both the Nck-dependent and the Nck-independent pathways, the latter of which uses an adaptor protein named Tir-cytoskeleton coupling protein (TccP/EspF U ). Genome analyses of the 1551-2 strain unveiled the existence of a gene encoding a putative novel TccP subtype in addition to a gene encoding for the TccP3 subtype. Amino-acid sequence comparison with known TccP subtypes (TccP/EspF U , TccP2, and TccP3) confirmed that the protein represents a novel TccP subtype—named here TccP4. Lack of TccP4 led to an approximately 96% reduction in the ability of the tccP3 deletion mutant of strain 1551-2 to induce the F-actin-rich pedestals formation in the infected Nck-null mouse embryonic fibroblasts (MEF) cells. The tccP4 gene was distributed widely in E. albertii , including the strains first separated from other E. albertii strains, suggesting that this gene was acquired at a very early stage during the diversification of E. albertii . The highly variable genetic organization of the tccP4 -containing regions and the presence of various mobile genetic elements in this region may explain the lack of tccP4 in E. albertii strains belonging to various lineages. IMPORTANCE: E. albertii , one of the new members of the genus Escherichia, is a diarrheagenic pathogen. The main characteristic of its pathogenicity is the formation of attaching and effacing (AE) lesions on the surface of infected epithelial cells. Here we identified a novel subtype of the TccP type 3 secretion system (T3SS) effector family (termed TccP4), which is required for the recruitment of F-actin during the AE lesion formation in infected host cells by the E. albertii 1551-2 strain. We also revealed that TccP4 is unique to E. albertii and widely distributed in this species, suggesting that the tccP4 gene was acquired at a very early stage during the diversification process of E. albertii . These findings expand our understanding of the function and diversity of this important T3SS effector family.
Biofilm formation by Escherichia coli can contribute to persistence and reduced susceptibility to antimicrobial treatment. Here, we evaluated treatment-associated changes following individual exposure to preparations of the glycosidases SdBgl1B and dispersin B (DspB) and the cysteine protease papain in assays assessing changes in preformed biofilm biomass and in biomass formed during 24 h of enzyme exposure across four E. coli strains (042, 1007, P180, and 23699) using static crystal violet microtiter-plate assays. The assays comprised three independent biological replicates with three technical wells per replicate for each condition. Papain-treated wells showed reductions in preformed crystal-violet-stained biomass of up to 92.4% for strain 042 at 1.00 mg/mL and 81.4–90.8% for strain 23699 across the tested concentration range. DspB-treated wells showed 67–72% less preformed biomass for strain 23699 and approximately 89% less biomass formed over 24 h by strain 042 at 0.03–0.06 mg/mL. Exposure to SdBgl1B was associated with variable responses, including approximately 62% less biomass formed by strain 042 at the enzyme concentration of 0.50 mg/mL. These percentages describe changes relative to the corresponding controls, not statistically established rankings among strains or enzymes. Several enzyme–strain combinations displayed non-monotonic responses, and some treatments produced crystal violet signals above the control. The control scheme does not resolve vehicle- or preparation-dependent staining contributions, precluding enzyme-specific causal attribution. Because crystal violet staining quantifies total attached stained material rather than specific matrix cleavage or bacterial viability, these findings document changes in the attached biomass endpoint but do not establish biofilm eradication, a molecular degradation mechanism, or bactericidal activity. Further matrix characterization, viability, dispersal, and confocal microscopy assays are required to determine mechanism and assess translational potential.